120
Participants
Start Date
September 30, 1997
Primary Completion Date
March 31, 2006
Study Completion Date
June 30, 2006
paclitaxel
Memorial Sloan-Kettering Cancer Center, New York
New York Presbyterian Hospital - Cornell Campus, New York
Mount Sinai Medical Center, NY, New York
CCOP - North Shore University Hospital, Manhasset
North Shore University Hospital, Manhasset
State University of New York - Upstate Medical University, Syracuse
CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C., Syracuse
CCOP - Christiana Care Health Services, Wilmington
Marlene and Stewart Greenebaum Cancer Center, University of Maryland, Baltimore
Duke Comprehensive Cancer Center, Durham
CCOP - Mount Sinai Medical Center, Miami Beach
University of Tennessee Cancer Institute, Memphis
University of Minnesota Cancer Center, Minneapolis
Barnes-Jewish Hospital, St Louis
Ellis Fischel Cancer Center - Columbia, Columbia
CCOP - Southern Nevada Cancer Research Foundation, Las Vegas
Rebecca and John Moores UCSD Cancer Center, La Jolla
UCSF Cancer Center and Cancer Research Institute, San Francisco
Walter Reed Army Medical Center, Washington D.C.
University of Chicago Cancer Research Center, Chicago
Holden Comprehensive Cancer Center, Iowa City
Dana-Farber Cancer Institute, Boston
University of Massachusetts Memorial Medical Center - University Campus, Worcester
University of Nebraska Medical Center, Omaha
Norris Cotton Cancer Center, Lebanon
Roswell Park Cancer Institute, Buffalo
Lineberger Comprehensive Cancer Center, UNC, Chapel Hill
CCOP - Southeast Cancer Control Consortium, Winston-Salem
Comprehensive Cancer Center at Wake Forest University, Winston-Salem
Rhode Island Hospital, Providence
Vermont Cancer Center, Burlington
MBCCOP - Massey Cancer Center, Richmond
National Cancer Institute (NCI)
NIH
Alliance for Clinical Trials in Oncology
OTHER